...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

I don't disagree with a lot of the criticism.  It can be difficult to distinguish between reality and wishful thinking.

Share
New Message
Please login to post a reply